Event Schedule
8:00 â 8:50
Bright Start: Welcome Coffee, Registration & Itinerary Collection
8:50 â 8:55
Welcome Address From World BI
8:55 â 9:00
Co-Chair Welcome Address
Eric Hajjar
Project Lead â Serious Bacterial Infections
Global Antibiotic R&D Partnership (GARDP)
Andreas Panteli
Director, Clinical Trial Recruitment / Operations / Health Equity
Novartis
9:00 - 9:25
Dr. Rafik FELLAGUE-CHEBRA
Executive Global Group Medical Director, Solid Tumors Franchise, GI Cancers
Novartis Oncology
Opening Keynote Presentation: Precision Oncology in Clinical Trials Dimension
9:25 - 9:50
Moderator:
Diane Chisholm
Head of Global Clinical Operations
Owkin
Problem Solution Matrix: How Patient and Site-Friendly Design Improves Trial Results
9:50 - 10:10
Matteo Talotta
Director of Clinical Solutions - Europe
Biorce
Partner Slot 1: AI-First Trial Design with Aika: Shortening Design Processes to Less Than 3 Months
10:10 - 11:00
Coffee Break Networking: Sip, Chat, Connect
Transforming Trials: A New Era of Patient-Centric Research
11:00 - 11:25
Next-Gen Panel: Smarter Trial Planning: Mining EHRs for Smarter, Faster Recruitment in Clinical Trials
Moderator:-
Isabela Niculae, MPH
End to End Digital Business Transformation Leader
UCB
Panellist:-
Stanislav Vartanov, MS
Independent Expert in Clinical Trials and Patient Engagement
Former Bayer
11:25 - 11:55
Patient Voice Panel: Voices of Impact: What Do Real Patients Actually Talk About?
Moderator:-
Mounia Chabane de Saint Aubin
Co-Founder and Global Head Research & Development
IAROD International Association for Rare Ophthalmic Diseases
Panellists:-
Yvette Venable
Global Market Acccess Payer Partnerships and Policy
AstraZeneca
Professor Lara Bloom
President and CEO
The Ehlers-Danlos Society
11:55 â 12:10
SanaClis
Partner Slot 2: TBC
12:10 - 12:20
Speed Networking Session
Scavenger Hunt Task: Exchange 5 Business Cards
12:20 â 12:40
Laura Risueño Ayerbe
Global Patient Affairs, Patient Engagement R&D
Servier
Deep Dive Session: Acting through Actions: Patient Engagement Approaches in R&D
12:40 â 13:05
Marlene Vincent
Head of Patient Advocacy
Intercept Pharmaceuticals
Presentation 1: How DCTs are Reshaping Patient Advocacy?
13:05 - 14:05
Lunch Break Dine & Discuss: Ideas on the Menu
Clinical Development â Rethinking Trial Design
14:05 â 14:30
Richardus Vonk
VP of Biometrics, Strategic Advisor
ITM Isotope Technologies Munich SE
Keynote Presentation: AI-Driven Evolution in Clinical Development
- How Artificial Intelligence is Reshaping Trial Design, Execution, and Data Analysis, With a Roadmap for Both Tactical Adoption and Long-Term Strategy
- Real-World Examples of AI-Driven Improvements in Predictive Modeling, Adaptive Execution, and Patient-Centered Research
- Actionable Approaches for Responsibly Integrating AI into Biometrics and Clinical Operations, Aligned with Regulatory Expectations and Advancing Patient-First Care
14:30 â 14:55
Bernhard Glombitza
Head Clinical Customer Engagement and Clinical Operations EMEA/LATAM
Bayer
Featured Presentation: Reimagining Clinical Operations: Navigating the Future of Efficiency and Innovation... an Outlook into the Year 2050
14:55 â 15:10
Partner Slot 3: TBC
15:10 â 15:35
Gabriel Westman
Head of Artificial Intelligence
Swedish Medical Products Agency (LĂ€kemedelsverk)
Deep Dive Presentation: AI in Clinical Development
- Study Design Optimization
- Intelligent Site Selection and Feasibility Assessment
- Patient Enrollment and Recruitment Strategies
- Safety Monitoring Using Real-Time AI Analytics
- Clinical Study Data Interpretation and Insights Generation
15:35 - 16:05
Coffee Break Networking: Sip, Chat, Connect
16:05 - 16:30
Co-Presentation: Navigating Clinical Trials: Integrating Operational Efficiency with Regulatory Strategy in Startups
Dagmara SĆaby
Regulatory Affairs Manager
JJP Biologics
Anna ĆosiĆska
Clinical Trial Specialist
JJP Biologics
16:30 â 16:55
Moderator:-
Rajeev Chavda
Senior Medical Director, Clinical Development
Panel Discussion: Clinical Trial Flops and Lessons Learned: Post Trial Innovation and Life Cycle Integration (Post Market Survillance Innovation)
Panellists:-
Eric Hajjar
Project Lead â Serious Bacterial Infections
Global Antibiotic R&D Partnership (GARDP)
Mounia Chabane de Saint Aubin
Co-Founder and Global Head Research & Development
IAROD International Association for Rare Ophthalmic Diseases
16:55 - 17:00
Chairs Closing Remarks
17:00
End of Day 1
8:00 â 8:50
Bright Start: Welcome Coffee, Registration & Itinerary Collection
8:50 â 8:55
Welcome Address From World BI
8:55 â 9:00
Co-Chair Welcome Address
Eric Hajjar
Project Lead â Serious Bacterial Infections
Global Antibiotic R&D Partnership (GARDP)
Andreas Panteli
Director, Clinical Trial Recruitment / Operations / Health Equity
Novartis
9:00 - 9:30
Thierry Schulmann
Medical Affairs Strategy
Sumitomo Pharma Switzerland
Deep Dive Session: Optimizing Clinical Trial Design and Execution Through Structured KOL Collaboration: Why Engaging KOLs is Essential for Clinical Trial Success
9:30 - 9:45
Partner Slot 4: TBC
9:45 - 10:10
Dr. Harsha Doddihal
Global Clinical Lead, Musculoskeletal
Telix Pharmaceuticals Limited
Deep Dive Presentation: Clinical Development of Radioligand Therapy
10:10 - 11:00
Coffee Break Networking: Sip, Chat, Connect
11:00 - 11:25
Ruba Jaber
Clinical Research & Development Director
Hikma Pharmaceuticals
Presentation 2: Bioequivalence Studies in Patients: Bridging Science and Digital Innovation for Smarter Trials
11:25 - 11:35
Snap & Share Contest
Give Attendees a Few Minutes to Snap a Picture that Captures the Essence of the Conference or a Specific Theme. Share it on LinkedIn, Tagging World BI. The Photo with the Most Likes Wins a Surprise Gift! Ready, set, SNAP!
11:35 - 12:00
Dorothy Bray, PhD
Director
CEITIC BIOTECH
Presentation 3: Challenges in Designing Phase I Studies in Oncology
Data Privacy Meets Data Potential â Harnessing Big Data & AI in Clinical Trials
12:00 - 12:25
Puja Myles
Director, Clinical Practice Research Datalink
Medicines and Healthcare Products Regulatory Agency
Featured Presentation: Can Fake Data Save Real Lives? Exploring Synthetic Data and Security in Clinical Trials
12:25 - 12:35
Speed Networking Session
One Question, Many Insights! đ€
12:35 - 13:00
Katharina Schreeb
Former VP, Clinical Development, Sangamo
Presentation 4: Challenges and Opportunities of AI (Blockchain and ML) in Drug Development
13:00 - 14:00
Lunch Break Dine & Discuss: Ideas on the Menu
14:00 - 14:25
Dr. Sachin Shah
Digital Biomarker Lead
GSK
Presentation 5: Harnessing Digital Health Technologies and Real-World Evidence to Enhance Clinical Research and Patient Outcomes
14:25 - 14:50
Agata Kinga Kaczmarek
Senior International Product Manager - Inflammation
Boehringer Ingelheim
Deep Dive Session: AI in Clinical Trials: How AI Can Help Connect Clinical Development with Market Adoption
14:50 - 15:20
Coffee Break Networking: Sip, Chat, Connect
Improving Clinical Quality
15:20 - 15:45
Michael von Forstner
Chief Scientific Officer
MedGenie AG
Presentation 6: Inclusion of Patient Preferences for Benefit and Risk Outcomes to Inform Clinical Trial Design
15:45 - 16:10
Amer Alghabban
R&D Quality Regulatory Authority Inspection Management
Bristol Myers Squibb
Deep Dive Session: TBC
16:10 - 16:35
Karen Dr. med. vet. Edelmann-Stergiou
Senior Principal Capability Manager
Boehringer Ingelheim
Presentation 7: Pioneering Sustainable Practices in Clinical Trials for a Healthier Future
16:35 - 16:45
Chairs Closing Remarks
16:45
